Pfizer and Moderna stocks drop after RFK Jr.'s nomination for Health Secretary: impact on the Pharma Industry

economictimes.indiatimes.com:

Pfizer and Moderna, saw significant declines following the announcement of Robert F. Kennedy Jr. as President-elect Donald Trump’s pick for Secretary of Health and Human Services.
Kennedy, a prominent figure in the anti-vaccine movement, has long propagated controversial views and conspiracy theories about vaccines, which could affect the future of public health policies.

Stock Market Reaction to RFK Jr.'s Nomination

On the morning after the nomination, Pfizer's stock dropped by more than 2%, with a continued slight decline in pre-market trading.

Also Read :9-1-1 Season 8: See Episode 8 release date, time, where to watch and plot

Moderna followed suit with a near 6% decrease in stock value, while AstraZeneca saw a dip of over 1%. Novavax and GlaxoSmithKline, both involved in the production of COVID-19 vaccines, suffered losses of over 7% and 4%, respectively, as mentioned in a report by Forbes.

• Artificial Intelligence(AI)

  AI and Analytics based Business Strategy

  By — Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI

• Leadership

  From Idea to Product: A Startup Development Guide

  By — Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience

• Finance

  Crypto & NFT Mastery: From Basics to Advanced

  By — CA Raj K Agrawal, Chartered Accountant

• Finance

  Financial Literacy i.e Lets Crack the Billionaire Code

  By — CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator

• Office Productivity

  Mastering Microsoft Office: Word, Excel, PowerPoint, and 365

  By